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The commentary 
Role of obesity in patients with cardiovascular disease
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Currently, obesity in most cases is defined as a body mass index (BMI) exceeding the 
threshold of 30 kg/m2. Obesity is associated with an excessive accumulation of the 
adipose tissue in various body regions. Adipose tissue tends to accumulate subcu-
taneously mostly on the abdomen and hips, but it can be also found around internal 
organs, including heart blood vessels etc. There are several causes of obesity, with the 
most important one being excessive calorie intake, but the genetic defects also have 
been identified and subcategorized into rare genes that produce significant obesity and 
a group of more common genes that underlie the propensity to develop obesity under 
permissive environmental conditions.
Adipose tissue is no longer considered as simple energy storage. Currently, we know that adipose tissue is one of the 
biggest and most important secretory organs in the human body. It produces a variety of different substances including 
free fatty acids, tumor necrosis factor alpha (TNF-α), complement components interleukins 6 (IL-6), 1 (IL-1), and most 
importantly adipokines with different biological role, including adipokine or visfatin [1].
Because of the complex role of the adipose tissue in human body, it has an imminent role in the pathogenesis, deve-
lopment and course of the number of disease, including those of the cardiovascular system. Cardiovascular disease 
is the leading cause of mortality and morbidity in the developed countries [2]. Epidemiological data show that approxi-
mately 35% are obese and 69% are either overweight or obese [3]. Taking into the consideration the fact that obesity 
is also a growing, global epidemics affecting both pediatric and adult populations, associated with a decreased life 
expectancy, its association with cardiovascular disease is especially important [4]. The relationship between obesity 
and cardiovascular disease has been widely studied, but a number of questions remain to be answered. This includes 
potential mechanism responsible for their association.
Adipose tissue causes local, as well as whole-body effects. Because of the close association between adipose tis-
sue and the heart muscle itself, special attention is drawn to the adipose tissue located in the immediate vicinity of 
the myocardium — epicardial adipose tissue. Its quantity and location are relatively easy to evaluate, and a growing 
number of studies show that it may be a good exponent of both risk of future cardiovascular events, as well as other 
diseases. Presence of epicardial adipose tissue is associated with an elevated risk of coronary artery disease, and as 
its consequence, myocardial infarction and death. Moreover, excess of epicardial adipose tissue has been linked with 
the risk of arterial hypertension, left ventricular dysfunction or atrial fibrillation.
Moreover, obesity causes non-local, but rather generalized changes in the body homeostasis. Obesity has been 
linked to development of diseases like atherosclerosis (including coronary heart disease, peripheral artery disease, 
and cerebral artery disease), heart failure and cardiac arrhythmias. In most cases it is due to the exacerbation of 
cardiovascular risk factors and comorbidities such as hypertension, dyslipidemia, glucose intolerance or diabetes 
and obstructive sleep apnea [5]. One of the potential mechanisms of this association was depicted in the paper by 
Zalewski et al. published in the present number of Folia Cardiologica. The Authors assessed the influence of obesity 
on hemodynamic, autonomic and cardiovascular function in a cohort of otherwise healthy, young males. The authors 
found that increased BMI was correlated with parameters of cardiac function, body fluid content and other parame-
ters considering autonomic function. The paper adds to the growing body of literature showing that obesity influences 
negatively cardiac structure and function, partially because of the hemodynamic overload.
Recent studies and meta-analyses showed that left ventricular hypertrophy is present in a consistent fraction of the 
obese population and that eccentric hypertrophy prevails over the concentric phenotype [6]. Moreover, adaptation to 
obesity consists of left-ventricular dilatation and hypertrophy (eccentric hypertrophy) irrespective of arterial pressure 
levels Obesity is also a risk factor for systolic/diastolic dysfunction. On the contrary, weight loss by means of caloric 
restriction or surgery results in favorable hemodynamic changes referred to as reverse remodeling and including 
regression of left ventricular mass and chamber size has been shown universally [7].
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It is worth mentioning that the literature also shows data on the so called “obesity paradox”, which is defined as a re-
duction of the risk of hospitalization, cardiovascular events and death due to increased BMI, particularly in patients 
with heart failure, but also coronary artery disease or stroke [8, 9]. In part in can be associated with an increased 
medical vigilance and intensified pharmacotherapy in obese patients, but the rationale and significance of this phe-
nomenon is inconclusive and remains to be discovered.
Nevertheless, it seems that obesity and fat accumulation have a negative impact on the development, progression 
and prognosis in majority of cardiovascular disease. The study by Binter et al. is another attempt to describe the patho-
physiological association of obesity with cardiovascular disease, which sheds the light on the undergoing mechanisms 
and stresses the importance of weight loss in cardiovascular disease prevention.
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